A preliminary study on the teratogenesis of dexamethasone and the preventive effect of vitamin B12 on murine embryonic palatal shelf fusion in vitro

Journal of Zhejiang University: Science B

Volumn 9, Issue 4, 2008, Pages 306-312

  Lu, Sheng Jun ^a   He, Wei ^a   Shi, Bing ^a   Meng, Tian ^a   Li, Xiao Yu ^a   Liu, Yu Rong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cleft palate; Dexamethasone; Medialedge epithelial cells; Organ culture; VitaminB12

Indexed keywords

CYANOCOBALAMIN; DEXAMETHASONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUSION; CELL PROLIFERATION; CLEFT PALATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TERATOGENESIS;

ANIMALS; CELL PROLIFERATION; CLEFT PALATE; DEXAMETHASONE; EPITHELIAL CELLS; FEMALE; GLUCOCORTICOIDS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; ORGAN CULTURE TECHNIQUES; TERATOGENS; TIME FACTORS; VITAMIN B 12;

MURINAE; MUS;

EID: 41749087353     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B0710625     Document Type: Article

References (40)

1. Abbott, B.D., Birnbaum, L.S., 1990a. TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD. Toxicol. Appl. Pharmacol., 106(3):418-432.
2. Abbott, B.D., Birnbaum, L.S., 1990b. Rat embryonic palatal shelves respond to TCDD in organ culture. Toxicol. Appl. Pharmacol., 103(3):441-451. [doi:10.1016/0041-008X(90) 90317-N]
3. Abbott, B.D., Birnbaum, L.S., 1990c. Retinoic acid-induced alterations in the expression of growth factors in embryonic mouse palatal shelves. Teratology, 42(6):597-610. [doi:10.1002/tera.1420420604]
4. Abbott, B.D., Diliberto, J.J., Birnbaum, L.S., 1989a. 2,3,7,8-tetrachlorodibenzo-p-dioxin alters embryonic palatal medial epithelial cell differentiation in vitro. Toxicol. Appl. Pharmacol., 100(1):119-131. [doi:10.1016/0041-008X(89)90096-3]
5. Abbott, B.D., Harris, M.W., Birnbaum, L.S., 1989b. Etiology of retinoic acid-induced cleft palate varies with the embryonic stage. Teratology, 40(6):533-553. [doi:10.1002/tera.1420400602]
6. Abbott, B.D., Diliberto, J.J., Birnbaum, L.S., 1992. Mechanisms of TCDD-induction of cleft palate: Insights from in vivo and in vitro approaches. Chemosphere, 25(1-2):75-78. [doi:10.1016/ 0045-6535(92)90483-8]
7. Abbott, B.D., Buckalew, A.R., DeVito, M.J., David R.P., Bryant, L., Schmid, J.E., 2003. EGF and TGF-α expression influence the developmental toxicity of TCDD: Dose response and AhR phenotype in EGF, TGF-α, and EGF+TGF-α knockout mice. Toxicol. Sci., 71(1):84-95. [doi:10.1093/toxsci/71.1.84]
8. Abbott, B.D., Best, D.S., Narotsky, M.G., 2005a. Teratogenic effects of retinoic acid are modulated in mice lacking expression of epidermal growth factor and transforming growth factor-alpha. Birth Defects Research Part A Clinical and Molecular Teratology, 73(4):204-217. [doi: 10.1002/bdra.20117]
9. Abbott, B.D., Buckalew, A.R., Leffler, K.E., 2005b. Effects of epidermal growth factor (EGF), transforming growth factor (TGF), and 2,3,7,8-tetrachlorodibenzo- p -dioxin on fusion of embryonic palates in serum-free organ culture using wild-type, EGF knockout, and TGF-α knockout mouse strains. Birth Defects Research Part A Clinical and Molecular Teratology, 73(6):447-454. [doi:10.1002/bdra. 20133]
10. Bock, K.W., Köhle, C., 2006. Ah receptor: Dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem. Pharmacol., 72 (4):393-404. [doi:10. 1016/j.bcp.2006.01.017]
11. Botto, L.D., Richard, S.J., Erickson, D., 2004. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am. J. Med. Genet. Part C: Semin. Med. Genet., 125C(1):12-21. [doi:10.1002/ ajmg.c.30004]
12. Carmichael, S.L., Shaw, G.M., Ma, C., Werler, M.M., Rasmussen, S.A., Lammer, E.J., 2007. Maternal corticosteroid use and orofacial clefts. Am. J. Obstet. Gynecol., 197 (6):585.e1-585.e7. [doi:10.1016/ j.ajog.2007.05.046]
13. Chou, M.J., Kosazuma, T., Takigawa, T., Yamada, S., Takahara, S., Shiota, K., 2004. Palatal shelf movement during palatogenesis: A fate map of the fetal mouse palate cultured in vitro. Anat. Embryol., 208(1):19-25. [doi:10. 1007/s00429-004-0379-0]
14. Degitz, S.J., Morris, D., George L., Foley, B., Francis, M., 1998. Role of TGF-β in RA-induced cleft palate in CD-1 mice. Teratology, 58 (5):197-204. [doi:10.1002/(SICI) 1096-9926(199811)58:5>197::AID-TERA6<3.0.CO;2-8]
15. Greene, R.M., Kochhar, D.M., 1975. Some aspects of corticosteroid-induced cleft palate: A review. Teratology, 11 (1):47-55. [doi:10.1002/tera.1420110106]
16. Gritli-Linde, A., 2007. Molecular control of secondary palate development. Dev. Biol., 301(2):309-326. [doi:10.1016/j. ydbio.2006.07.042]
17. Hackney, J.F., 1980. A glucocorticoid receptor in fetal mouse: Its relationship to cleft palate formation. Teratology, 21(1):39-51. [doi:10.1002/tera.1420210106]
18. Hassell, J.R., 1975. The development of rat palatal shelves in vitro: An ultrastructural analysis of the inhibition of epithelial cell death and palate fusion by the epidermal growth factor. Dev. Biol., 45(1):90-102. [doi:10.1016/0012-1606(75)90244-4]
19. Hassoun, E.M., Dencker, L., 1982. TCDD embryo toxicity in the mouse may be enhanced by β-naphthoflavone, another ligand of the Ah-receptor. Toxicol. Lett., 12(2-3):191-198. [doi:10.1016/0378-4274(82)90185-0]
20. Herrmann, M., Schmidt, J., Umanskaya, N., Colaianni, G., Al Marrawi, F., Widmann, T., Zallone, A., Wildemann, B., Herrmann, W., 2007. Stimulation of osteoclast activity by low B-vitamin concentrations. Bone, 41(4):584-591. [doi:10.1016/j.bone.2007.06.005]
21. Koch, W.E., Smiley, G.R., 1981. In-vivo and in-vitro studies of the development of the avian secondary palate. Arch. Oral Biol., 26(3):181-187. [doi:10.1016/0003-9969(81) 90128-X]
22. Krapels, I.P.C., van Rooij, I.A.L.M., Ocké, M.C., van Cleef, B.A.G.L., Kuijpers-Jagtman, A.M., Steegers-Theunissen, R.P.M., 2004. Maternal dietary B vitamin intake, other than folate, and the association with orofacial cleft in the offspring. Eur. J. Nutr., 43(1):7-14. [doi:10.1007/s00394-004-0433-y]
23. Kusanagi, T., 1984. Sensitive stages and dose-response analyses of palatal slit and cleft palate in C57BL/6 mice treated with a glucocorticoid. Teratology, 29(2):281-286. [doi:10.1002/tera.1420290214]
24. Miettinen, H.M., Huuskonen, H., Partanen, A.M., Miettinen, P., Tuomisto, J.T., Pohjanvirta, R., Tuomisto, J., 2004. Effects of epidermal growth factor receptor deficiency and 2,3,7,8-tetrachlorodibenzo- p -dioxin on fetal development in mice. Toxicol. Lett., 150 (3):285-291. [doi:10.1016/ j.toxlet.2004.02.009]
25. Montenegro, M.A., Palomino, H., 1989. Inhibition of palatal fusion in vitro by indomethacin in two strains of mice with different H-2 backgrounds. Arch. Oral Biol., 34(12):949-955. [doi:10.1016/ 0003-9969(89)90051-4]
26. 12. Int. J. Oral Maxillofac. Surg., 15(6):752-755.
27. Newall, D.R., Edwards, J.R.G., 1981. The effect of vitamin A on fusion of mouse palates. I. Retinyl palmitate and retinoic acid in vivo. Teratology, 23(1):115-124. [doi:10. 1002/tera.1420230114]
28. Nugent, P., Ma, L., Greene, R.M., 1998. Differential expression and biological activity of retinoic acid-induced TGFβ isoforms in embryonic palate mesenchymal cells. J. Cell. Physiol., 177(1):36-46. [doi:10.1002/(SICI)1097-4652(19 9810)177:1>36::AID-JCP4<3.0.CO;2-F]
29. Pourtois, M., 1966. Onset of the acquired potentiality for fusion in the palatal shelves of rats. J. Embryol. Exp. Morphol., 16(1):171-182.
30. Pratt, R.M., Perry, E.L., Chapman, L.M., Goulding, E.H., 1984. Glucocorticoid teratogenesis in mouse whole embryo culture. Teratology, 30(1):71-81. [doi:10.1002/tera.1420 300110]
31. Rice, D.P., 2005. Craniofacial anomalies: From development to molecular pathogenesis. Curr. Mol. Med., 5(7):699-722. [doi:10.2174/ 156652405774641043]
32. Ryan, R.P., Sunahara, G.I., Lucier, G.W., Birnbaum, L.S., Nelson, K.G., 1989. Decreased ligand binding to the hepatic glucocorticoid and epidermal growth factor receptors after 2,3,4,7,8-pentachlorodibenzofuran and 1,2,3,4,7, 8-hexachlorodibenzofuran treatment of pregnant mice. Toxicol. Appl. Pharmacol., 98(3):454-464. [doi:10.1016/0041-008X(89)90174-9]
33. 6 and one carbon metabolism. J. Nutr. Health Aging, 6(1):39-42.
34. Shah, R.M., Chen, Y.P., Burdett, D.N., 1989. Growth of the secondary palate in the hamster following hydrocortisone treatment: Shelf area, cell number, and DNA synthesis. Teratology, 40(2):173-180. [doi:10.1002/ tera.1420400211]
35. Shimizu, N., Aoyama, H., Hatakenaka, N., Kaneda, M., Teramoto, S., 2001. An in vitro screening system for characterizing the cleft palate-inducing potential of chemicals and underlying mechanisms. Reprod. Toxicol., 15(6):665-672. [doi:10.1016/S0890-6238(01)00175-7]
36. 12, vitamin A, folic acid, and fetal malformations. Reprod. Toxicol., 13(1):53-57. [doi:10.1016/ S0890-6238(98)00058-6]
37. van Rooij, I.A., Swinkels, D.W., Blom, H.J., Merkus, H.M., Steegers-Theunissen, R.P., 2003. Vitamin and homocysteine status of mothers and infants and the risk of nonsyndromic orofacial clefts. Am. J. Obstet. Gynecol., 189(4):1155-1160. [doi:10.1067/ S0002-9378(03)00592-1]
38. Vargas, V.I., 1967. Palatal fusion in vitro in the mouse. Arch. Oral Biol., 12(11):1283-1288. [doi:10.1016/0003-9969 (67)90130-6]
39. Vujkovic, M., Ocke, M.C., van der Spek, P.J., Yazdanpanah, N., Steegers, E.A., Steegers-Theunissen, R.P., 2007. Maternal western dietary patterns and the risk of developing a cleft lip with or without a cleft palate. Obstet. Gynecol., 110 (2 Pt 1):378-384.
40. 12, and homocysteine. Ann. Anat., 189(3):229-233.